Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bevan

Showing results (71-80 of 336) with videos related to

Pageof 34
Sort By:
ACS Chemical Neuroscience|November 23, 2012
The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's diseaseJustin A Lemkul, David R Bevan
Journal of Toxicology and Environmental Health|January 1, 1985
Elution of benzo[a]pyrene from carbon blacks into biomembranes in vitroD R Bevan, W J Worrell
Chemico-Biological Interactions|December 17, 1985
Effect of particulates on metabolism and mutagenicity of benzo[a]pyreneD R Bevan, W E Manger
Lancet (London, England)|November 9, 1974
Letter: Chronic renal failure and major surgeryD R Bevan, H A Dudley
The Journal of Physical Chemistry. B|June 3, 2011
Characterization of interactions between PilA from Pseudomonas aeruginosa strain K and a model membraneJustin A Lemkul, David R Bevan
Biochemistry|June 21, 2011
Steered molecular dynamics simulations reveal important mechanisms in reversible monoamine oxidase B inhibitionWilliam J Allen, David R Bevan
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 1995
Clindamycin-induced neuromuscular blockadeO al Ahdal, D R Bevan
The Journal of Physical Chemistry. B|January 9, 2010
Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamicsJustin A Lemkul, David R Bevan
Biochemical and Biophysical Research Communications|June 29, 2007
Molecular docking of inhibitors into monoamine oxidase BWilliam T Harkcom, David R Bevan
Cancer Research|July 15, 1993
Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitroD P Ankrapp, D R Bevan
Pageof 34

Showing results (71-80 of 336) with videos related to

Sort By:
Pageof 34
ACS Chemical Neuroscience|November 23, 2012
The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's diseaseJustin A Lemkul, David R Bevan
Journal of Toxicology and Environmental Health|January 1, 1985
Elution of benzo[a]pyrene from carbon blacks into biomembranes in vitroD R Bevan, W J Worrell
Chemico-Biological Interactions|December 17, 1985
Effect of particulates on metabolism and mutagenicity of benzo[a]pyreneD R Bevan, W E Manger
Lancet (London, England)|November 9, 1974
Letter: Chronic renal failure and major surgeryD R Bevan, H A Dudley
The Journal of Physical Chemistry. B|June 3, 2011
Characterization of interactions between PilA from Pseudomonas aeruginosa strain K and a model membraneJustin A Lemkul, David R Bevan
Biochemistry|June 21, 2011
Steered molecular dynamics simulations reveal important mechanisms in reversible monoamine oxidase B inhibitionWilliam J Allen, David R Bevan
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 1995
Clindamycin-induced neuromuscular blockadeO al Ahdal, D R Bevan
The Journal of Physical Chemistry. B|January 9, 2010
Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamicsJustin A Lemkul, David R Bevan
Biochemical and Biophysical Research Communications|June 29, 2007
Molecular docking of inhibitors into monoamine oxidase BWilliam T Harkcom, David R Bevan
Cancer Research|July 15, 1993
Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitroD P Ankrapp, D R Bevan
Pageof 34